Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

Daratumumab (DARA) is a human CD38-specific IgG1 antibody that is in clinical development for the treatment of multiple myeloma (MM). The potential for IgG1 antibodies to induce macrophage-mediated phagocytosis, in combination with the known presence of macrophages in the tumor microenvironment in M...

Descripción completa

Detalles Bibliográficos
Autores principales: Overdijk, Marije B, Verploegen, Sandra, Bögels, Marijn, van Egmond, Marjolein, van Bueren, Jeroen J Lammerts, Mutis, Tuna, Groen, Richard WJ, Breij, Esther, Martens, Anton CM, Bleeker, Wim K, Parren, Paul WHI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622648/
https://www.ncbi.nlm.nih.gov/pubmed/25760767
http://dx.doi.org/10.1080/19420862.2015.1007813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622648/
https://www.ncbi.nlm.nih.gov/pubmed/25760767
http://dx.doi.org/10.1080/19420862.2015.1007813

Ejemplares similares